CBP501 suppresses macrophage induced cancer stem cell like features and metastases

CBP501 is an anti-cancer drug candidate which has been shown to increase cis-diamminedichloro-platinum (II) (CDDP) uptake into cancer cell through calmodulin (CaM) inhibition. However, the effects of CBP501 on the cells in the tumor microenvironment have not been addressed. Here, we investigated new...

Descripción completa

Detalles Bibliográficos
Autores principales: Mine, Naoki, Yamamoto, Sayaka, Saito, Naoya, Sato, Takuji, Sakakibara, Keiichi, Kufe, Donald W., VonHoff, Daniel D., Kawabe, Takumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609981/
https://www.ncbi.nlm.nih.gov/pubmed/28969049
http://dx.doi.org/10.18632/oncotarget.19292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609981/
https://www.ncbi.nlm.nih.gov/pubmed/28969049
http://dx.doi.org/10.18632/oncotarget.19292

Ejemplares similares